Literature DB >> 23143871

Specification of functional neurons and glia from human pluripotent stem cells.

Yuan Jiang1, Mei-Jiang Zhang, Bao-Yang Hu.   

Abstract

Human pluripotent stem cells (PSCs) such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) hold great promise in regenerative medicine as they are an important source of functional cells for potential cell replacement. These human PSCs, similar to their counterparts of mouse, have the full potential to give rise to any type of cells in the body. However, for the promise to be fulfilled, it is necessary to convert these PSCs into functional specialized cells. Using the developmental principles of neural lineage specification, human ESCs and iPSCs have been effectively differentiated to regional and functional specific neurons and glia, such as striatal gama-aminobutyric acid (GABA)-ergic neurons, spinal motor neurons and myelin sheath forming oligodendrocytes. The human PSCs, in general differentiate after the similar developmental program as that of the mouse: they use the same set of cell signaling to tune the cell fate and they share a conserved transcriptional program that directs the cell fate transition. However, the human PSCs, unlike their counterparts of mouse, tend to respond divergently to the same set of extracellular signals at certain stages of differentiation, which will be a critical consideration to translate the animal model based studies to clinical application.

Entities:  

Mesh:

Year:  2012        PMID: 23143871      PMCID: PMC4875461          DOI: 10.1007/s13238-012-2086-6

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  51 in total

1.  Stem cells and early lineage development.

Authors:  Janet Rossant
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

Review 2.  Intracellular signaling pathways regulating pluripotency of embryonic stem cells.

Authors:  Keisuke Okita; Shinya Yamanaka
Journal:  Curr Stem Cell Res Ther       Date:  2006-01       Impact factor: 3.828

3.  Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice.

Authors:  Lixiang Ma; Baoyang Hu; Yan Liu; Scott Christopher Vermilyea; Huisheng Liu; Lu Gao; Yan Sun; Xiaoqing Zhang; Su-Chun Zhang
Journal:  Cell Stem Cell       Date:  2012-03-15       Impact factor: 24.633

4.  Direct reprogramming of fibroblasts into neural stem cells by defined factors.

Authors:  Dong Wook Han; Natalia Tapia; Andreas Hermann; Kathrin Hemmer; Susanne Höing; Marcos J Araúzo-Bravo; Holm Zaehres; Guangming Wu; Stefan Frank; Sören Moritz; Boris Greber; Ji Hun Yang; Hoon Taek Lee; Jens C Schwamborn; Alexander Storch; Hans R Schöler
Journal:  Cell Stem Cell       Date:  2012-03-22       Impact factor: 24.633

5.  Glial and neuronal differentiation in the human fetal brain 9-23 weeks of gestation.

Authors:  M Wilkinson; R Hume; R Strange; J E Bell
Journal:  Neuropathol Appl Neurobiol       Date:  1990-06       Impact factor: 8.090

6.  Induced expression of Olig2 is sufficient for oligodendrocyte specification but not for motoneuron specification and astrocyte repression.

Authors:  Zhong-Wei Du; Xue-Jun Li; Giang D Nguyen; Su-Chun Zhang
Journal:  Mol Cell Neurosci       Date:  2006-10-10       Impact factor: 4.314

7.  Differentiation of spinal motor neurons from pluripotent human stem cells.

Authors:  Bao-Yang Hu; Su-Chun Zhang
Journal:  Nat Protoc       Date:  2009-08-20       Impact factor: 13.491

8.  Induced pluripotent stem cells from a spinal muscular atrophy patient.

Authors:  Allison D Ebert; Junying Yu; Ferrill F Rose; Virginia B Mattis; Christian L Lorson; James A Thomson; Clive N Svendsen
Journal:  Nature       Date:  2008-12-21       Impact factor: 49.962

9.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

10.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

View more
  8 in total

1.  Reprogramming of COPD lung fibroblasts through formation of induced pluripotent stem cells.

Authors:  Hesham Basma; Yoko Gunji; Shunichiro Iwasawa; Amy Nelson; Maha Farid; Jun Ikari; Xiangde Liu; Xingqi Wang; Joel Michalski; Lynette Smith; Javeed Iqbal; Radwa El Behery; William West; Sowmya Yelamanchili; Deborah Rennard; Olaf Holz; Kai-Christian Mueller; Helgo Magnussen; Klaus Rabe; Peter J Castaldi; Stephen I Rennard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-31       Impact factor: 5.464

2.  Zinc finger E-box-binding homeobox 1 (ZEB1) is required for neural differentiation of human embryonic stem cells.

Authors:  Yuan Jiang; Long Yan; Longkuo Xia; Xiaoyin Lu; Wenliang Zhu; Dewen Ding; Mingxia Du; Da Zhang; Hongmei Wang; Baoyang Hu
Journal:  J Biol Chem       Date:  2018-10-18       Impact factor: 5.157

3.  Endogenous WNT signaling regulates hPSC-derived neural progenitor cell heterogeneity and specifies their regional identity.

Authors:  Noel Moya; Josh Cutts; Terry Gaasterland; Karl Willert; David A Brafman
Journal:  Stem Cell Reports       Date:  2014-11-13       Impact factor: 7.765

Review 4.  Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative Diseases.

Authors:  Shripriya Singh; Akriti Srivastava; Pranay Srivastava; Yogesh K Dhuriya; Ankita Pandey; Dipak Kumar; Chetan S Rajpurohit
Journal:  Front Mol Biosci       Date:  2016-11-08

Review 5.  Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies.

Authors:  Syed A Ali; Ning Yin; Arkam Rehman; Verline Justilien
Journal:  Med Sci (Basel)       Date:  2016-01-20

6.  Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing.

Authors:  Francesca Pistollato; David Canovas-Jorda; Dimitra Zagoura; Anna Price
Journal:  J Vis Exp       Date:  2017-06-09       Impact factor: 1.355

Review 7.  Potential of Cellular Therapy for ALS: Current Strategies and Future Prospects.

Authors:  Ting-Jung Lin; Guang-Chao Cheng; Luo-Yun Wu; Wei-Yu Lai; Thai-Yen Ling; Yung-Che Kuo; Yen-Hua Huang
Journal:  Front Cell Dev Biol       Date:  2022-03-16

Review 8.  Stem cell transplantation therapy in Parkinson's disease.

Authors:  Mu-Hui Fu; Chia-Ling Li; Hsiu-Lien Lin; Pei-Chun Chen; Marcus J Calkins; Yu-Fan Chang; Pei-Hsun Cheng; Shang-Hsun Yang
Journal:  Springerplus       Date:  2015-10-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.